Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Eisai announces Data from the Phase II Clinical Trial of BAN2401

biospectrumasiaOctober 29, 2018

Tag: Eisai , antibody , Alzheimer's Disease

PharmaSources Customer Service